As of 2025-06-20, the Intrinsic Value of Goldseek Resources Inc (GSK.CN) is -0.04 CAD. This GSK.CN valuation is based on the model Peter Lynch Fair Value. With the current market price of 0.51 CAD, the upside of Goldseek Resources Inc is -107.17%.
Based on its market price of 0.51 CAD and our intrinsic valuation, Goldseek Resources Inc (GSK.CN) is overvalued by 107.17%.
Note: result may not be accurate due to the invalid valuation result of Peter Lynch's fair value model.
| Range | Selected | Upside | |
| a | |||
| Fair Value | -0.04 - -0.04 | -0.04 | -107.17% |
| P/E | (0.05) - (0.07) | (0.06) | -111.8% |
| DDM - Stable | (0.14) - (0.50) | (0.32) | -162.2% |
| DDM - Multi | (0.11) - (0.33) | (0.17) | -132.7% |
| Market Cap (mil) | 7.56 |
| Beta | 1.13 |
| Outstanding shares (mil) | 14.83 |
| Enterprise Value (mil) | 6.53 |
| Market risk premium | 5.50% |
| Cost of Equity | 10.48% |
| Cost of Debt | 5.00% |
| WACC | 7.54% |